Pricing Log in Create free account

Biorestorative Therapies, Inc. (BRTX) vs Kairos Pharma, Ltd. (KAPA)

Biorestorative Therapies, Inc. and Kairos Pharma, Ltd. are both Biotechnology companies. Kairos Pharma, Ltd. is the larger, with a market value of $2.3M against $2.0M — 1.1× the size. Kairos Pharma, Ltd. has the higher net margin (0.00% vs −3,089.3%) and the lower return on invested capital (−322.9% vs 0.00%). Across the 13 metrics below, Kairos Pharma, Ltd. leads on 11 and Biorestorative Therapies, Inc. on 2.

Valuation

Metric BRTX KAPA Biotechnology median
P/E n/m n/m 8.50
P/S 3.76 n/m 9.71
P/B 0.45 0.44 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.15 0.14 0.64
EV/Sales (5.74) n/m 9.21
Earnings yield (1,407.89%) (326.58%) (33.15%)
Free cash flow yield (972.97%) (216.16%) (25.50%)

Profitability

Metric BRTX KAPA Biotechnology median
Gross margin 92.09% — 65.16%
Operating margin (3,974.66%) 0.00% 0.00%
Net margin (3,089.30%) 0.00% 0.00%
Free cash flow margin (3,302.04%) 0.00% 0.00%
Return on equity (241.50%) (113.96%) (56.36%)
Return on assets (147.75%) (104.32%) (48.04%)
Return on invested capital 0.00% (322.91%) 0.00%

Growth

Metric BRTX KAPA Biotechnology median
Revenue growth (TTM) (8.47%) — 6.02%
EPS growth (last fiscal year) (36.21%) (30.44%) 30.26%
Revenue growth, 5-year CAGR 36.11% — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BRTX KAPA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.35 11.98 4.72
Net debt to EBITDA 0.19 1.65 0.96

Dividend

Metric BRTX KAPA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BRTX KAPA Biotechnology median
Market cap 2.01m 2.27m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack